A phosphorothioate oligonucleotide blocks reverse transcription via an antisense mechanism
Related Experiment Videos
C Boiziau1, S Moreau, J J Toulmé
1Laboratoire de Biophysique Moléculaire, INSERM U 386, Université de Bordeaux II, France.
Abstract:
We have studied the inhibition by a phosphorothioate oligodeoxynucleotide (17PScap) of cDNA synthesis performed by either avian or murine reverse transcriptase. Three different mechanisms of inhibition were identified: at low concentrations (< 100 nM), the cleavage of the RNA template by the retroviral RNase H at the level of the RNA/17PScap duplex accounted for most of the effect, whereas hybrid-arrested cDNA synthesis by an RNase H-independent mechanism marginally contributed to the inhibition. Both mechanisms were sequence-specific. Above 100 nM, the overall cDNA synthesis was reduced in a non-specific manner.
Insights
Phosphorothioate oligodeoxynucleotides inhibit reverse transcriptase-mediated cDNA synthesis through sequence-specific RNA template cleavage and hybrid arrest. At higher concentrations, non-specific inhibition of cDNA synthesis occurs.
Area of Science:
- Molecular Biology
- Virology
- Biochemistry
Background:
- Reverse transcriptase enzymes are crucial for retroviral replication and cDNA synthesis.
- Oligodeoxynucleotides are short DNA sequences with potential therapeutic and research applications.
- Understanding inhibition mechanisms is key to developing targeted antiviral or molecular biology tools.
Purpose of the Study:
- To investigate the inhibitory effects of a phosphorothioate oligodeoxynucleotide (17PScap) on avian and murine reverse transcriptase.
- To elucidate the mechanisms underlying 17PScap-mediated inhibition of cDNA synthesis.
Main Methods:
- Studied inhibition of cDNA synthesis using avian and murine reverse transcriptase.
- Utilized phosphorothioate oligodeoxynucleotide (17PScap) as an inhibitor.
- Analyzed inhibition mechanisms at varying concentrations (< 100 nM and > 100 nM).
Main Results:
- At low concentrations (< 100 nM), inhibition was primarily due to sequence-specific RNA template cleavage by RNase H at the RNA/17PScap duplex.
- A minor contribution from hybrid-arrested cDNA synthesis (RNase H-independent) was observed at low concentrations, also sequence-specific.
- Above 100 nM, cDNA synthesis was reduced via a non-specific inhibitory mechanism.
Conclusions:
- 17PScap exhibits dual mechanisms of inhibiting reverse transcriptase activity.
- Low-concentration inhibition is sequence-specific, involving RNase H-dependent and independent pathways.
- High-concentration inhibition is non-specific, broadly reducing overall cDNA synthesis.